Jun 25, 2001|
Biotech in agriculture
Agriculture in India offers tremendous opportunities and challenges. The country is climatically favorable for cultivation of every commercially important plant species grown in other parts of the world. Though the country is among the top three producers of tea, cotton, sugar and food grains, the productivity levels are far from satisfactory. The main challenge for India is to be able to produce enough food for the increasing population. As our population continues to grow, we are fast running out of arable land and water. Based on the current trends, India’s population will jump to around 1.5-1.6 bn, before stabilizing sometime in the middle of the 21st century. The world food demand is expected to triple by the same time and production is finding hard to catch up. India has bigger threat considering that it is one of the large consumers.
Biotechnology has some answers. It is now possible to isolate genes with favorable properties, and incorporate them into the seeds directly. Apart from yield enhancements and shorter crop gestation, genetically engineered seeds are inherently pest resistant. This science is widely known as seed biotechnology, makes food a large opportunity for agri-business. The total seed market in India is estimated at US$ 500 m. However, the penetration of hybrid seeds is barely at 30% of our total crop production. Thus, opportunities are enormous given the low penetration levels. Apart from the market for genetically developed seeds, biotechnology finds application in broad spectrum of agrochemicals.
Again, while traditional plant breeding involves the crossing of hundreds or thousands of genes, plant biotechnology allows for the transfer of only one or a few desirable genes. This more precise science allows plant breeders to develop crops with specific beneficial traits and without undesirable traits. Plant biotechnology is an extension of this traditional plant breeding with one very important difference - plant biotechnology allows for the transfer of a greater variety of genetic information in a more precise, controlled manner.
Biotech can thus offer several beneficial traits to agriculture. Apart from increasing productivity it also offers other quality improvements in terms of processing advantages, such as tomatoes with higher solids content; and nutrition enhancements, such as oil seeds that produce oils with lower saturated fat content. But it is may all remain a pipe dream unless India jumps on the biotechnology bandwagon aggressively.
More Views on News
Jun 2, 2017
Tata Chemicals registers 54.2% YoY rise in net profits during fourth quarter of FY17 on the back of lower finance costs and rise in other income.
Nov 18, 2016
Tata Chemicals has reported consolidated topline fall of 17% YoY while the bottomline has fallen 5% YoY
Aug 18, 2016
Tata Chemicals has reported consolidated topline fall of 9% YoY while the bottomline has grown 40% YoY.
Mar 2, 2016
Tata Chemicals has reported consolidated topline fall of 4% YoY while the bottom line has fallen 45% YoY
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407